Danaher Corp.
Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $225.77
- 52-Week Range
- $160.93 – $242.80
- Market Cap
- $160.81B
- P/E (TTM)
- 37.84
- EPS (TTM)
- 6.04
- Dividend Yield
- 0.70%
Advanced Metrics
- Price/Book
- 3.00
- PEG Ratio
- 1.30
- Return on Equity
- 8.19%
- Return on Assets
- 4.06%
- Gross Margin
- 59.36%
- Operating Margin
- 21.97%
- Profit Margin
- 16.91%
- Current Ratio
- 1.63
- Debt/Equity
- 0.52
- Total Debt
- $27.78B
- Free Cash Flow
- $4.75B
- Revenue Growth
- 8.30%
- Earnings Growth
- 37.80%
- Enterprise Value
- $182.93B
Market Snapshot
About
Danaher Corp. is a diversified science and technology company that designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company operates through three primary segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. Danaher's portfolio includes leading brands in biotechnology tools, clinical diagnostics, water quality analysis, and product identification. The company is known for its Danaher Business System, a management approach focused on continuous improvement and lean manufacturing principles. Danaher has a strong track record of acquiring and integrating businesses to expand its technology platform and global market presence.